loading...

COA Instruments Distributed by Mapi Research Trust

default distrib

AQLQ-M / Asthma Quality of Life Questionnaire - Marks Asthma Quality of Life Questionnaire - Marks

Marks GB, Dunn M, Woolcock AJ et al.

To measure the impact of asthma on quality of life

Therapeutic indications : Asthma

default distrib

ASI / Addiction Severity Index Addiction Severity Index

McLellan AT, Luborsky L, Woody GE, O'Brien CP et al.

To produce a problem severity profile of each patient through an analysis of six general areas

Therapeutic indications : Substance-Related Disorders, Alcoholism

default distrib

ASK-12 / Adherence Starts with Knowledge 12 Adherence Starts with Knowledge 12

GlaxoSmithKline Research and Development Limited (GSK) et al.

To measure barriers to medication adherence and adherence-related behavior.

Therapeutic indications : All

default distrib

ASK-20 / Adherence Starts with Knowledge 20 Adherence Starts with Knowledge 20

GlaxoSmithKline Research and Development Limited (GSK) et al.

To measure barriers to medication adherence and adherence-related behavior

Therapeutic indications : All

default distrib

ASRS / Augmentation Severity Rating Scale Augmentation Severity Rating Scale

The European Restless Legs Syndrome Study Group (EURLSSG) et al.

To assess severity of augmentation, the main complication during long-term dopaminergic treatment of restless legs syndrome (RLS)

Therapeutic indications : Restless Legs Syndrome

default distrib

AUQUEI / Pictured Child’s Quality of Life Self Questionnaire Pictured Child’s Quality of Life Self Questionnaire

Dazord A, Manificat S et al.

To assess the child’s subjective Quality of Life

Therapeutic indications : All

default distrib

Barthel Index / Barthel Index Barthel Index

Mahoney FI, Barthel DW et al.

To measure a person's daily functioning specifically the activities of daily living (ADL) and mobility

Therapeutic indications : All

default distrib

BAS-G / Bath Ankylosing Spondylitis Global score Bath Ankylosing Spondylitis Global score

Jones SD, Steiner A, Garrett SL, Calin A et al.

To reflect the effect of ankylosing spondylitis (AS) on the patient's well-being

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASDAI / Bath Ankylosing Spondylitis Disease Activity Index Bath Ankylosing Spondylitis Disease Activity Index

Calin A et al.

To define disease activity in patients with ankylosing spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASFI / Bath Ankylosing Spondylitis Functional Index Bath Ankylosing Spondylitis Functional Index

Calin A et al.

To define and monitor functional ability in patients with ankylosing spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASMI / Bath Ankylosing Spondylitis Metrology Index Bath Ankylosing Spondylitis Metrology Index

Calin A et al.

To define clinically significant changes in spinal movement

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASRI-h / Bath Ankylosing Spondylitis Radiology Index - Hip Bath Ankylosing Spondylitis Radiology Index - Hip

Mackay K, Brophy S, Mack C, Calin A, Doran M, Santos H et al.

To grade hip radiological changes in patients with Ankylosing Spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASRI-s / Bath Ankylosing Spondylitis Radiology Index - Spine Bath Ankylosing Spondylitis Radiology Index - Spine

Calin A, Mack C, Mackay K, Santos H, Brophy S et al.

To grade spin radiographic changes in patients with Ankylosing Spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BAT / Bladder Assessment Tool Bladder Assessment Tool

Astellas Pharma Europe Ltd et al.

To assess Overactive Bladder (OAB) symptoms, impact, bother, and treatment satisfaction

Therapeutic indications : Urinary Bladder, Overactive

default distrib

BDI-TDI / Baseline and Transition Dyspnea Indexes Baseline and Transition Dyspnea Indexes

Mahler DA et al.

To provide a multidimensional measurement of dyspnea based on activities of daily living in symptomatic individuals

Therapeutic indications : Asthma, Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive

default distrib

BENS Score / Bowel Endometriosis Syndrome Score Bowel Endometriosis Syndrome Score

Riiskjær M, Egekvist AG, Hartwell D, Forman A, Seyer-Hansen M, Kesmodel US et al.

To identify women with BENS and to monitor the effect of medical and surgical treatment of women suffering from bowel endometriosis

Therapeutic indications : Endometriosis

default distrib

BF-Diary / Bowel Function Diary Bowel Function Diary

Janssen Global Services, LLC (USA), Mapi et al.

To capture comprehensively the relevant patient information about opioid-induced constipation (OIC) in a clinical trial setting.

Therapeutic indications : Opioid-Related Disorders, Constipation, Pain

default distrib

BHQ / Bronchial Hyperresponsiveness Questionnaire Bronchial Hyperresponsiveness Questionnaire

van der Molen T et al.

To measure patient perceived bronchial hyperresponsiveness

Therapeutic indications : Asthma, Pulmonary Disease, Chronic Obstructive

default distrib

BITSEA / Brief Infant Toddler Social Emotional Assessment Brief Infant Toddler Social Emotional Assessment

Briggs-Gowan MJ, Irwin JR, Wachtel K, Carter AS, Cicchetti DV et al.

To identify social-emotional/behavioral problems and delays in competence in 12- to 36-month-olds

Therapeutic indications : Developmental Disabilities

default distrib

BL-VAS / Bond-Lader VAS (Mood Rating Scale) Bond-Lader VAS (Mood Rating Scale)

Bond A, Lader M et al.

To rate subjective feelings

Therapeutic indications : All